Earnings
TJX Posts Strong Q3 Results and Raises Full-Year Targets
TJX posted Q3 EPS of $1.28 on $15.1 billion in revenue, beating expectations and prompting the company to raise its FY26 guidance.
BTC$63,842.00-1.34%
ETH$1,853.15-1.82%
USDT$0.9991-0.01%
USDC$0.99990.00%
XRP$1.09-1.99%
SOL$73.73-3.02%
TRX$0.3302+1.20%
FIGR_HELOC$1.04+3.79%
HYPE$58.71+0.10%
DOGE$0.0686-1.50%
RAIN$0.0142+0.90%
USDS$0.9999+0.01%
LEO$9.64-0.88%
ZEC$490.88-4.53%
XMR$358.43+1.99%
BTC$63,842.00-1.34%
ETH$1,853.15-1.82%
USDT$0.9991-0.01%
USDC$0.99990.00%
XRP$1.09-1.99%
SOL$73.73-3.02%
TRX$0.3302+1.20%
FIGR_HELOC$1.04+3.79%
HYPE$58.71+0.10%
DOGE$0.0686-1.50%
RAIN$0.0142+0.90%
USDS$0.9999+0.01%
LEO$9.64-0.88%
ZEC$490.88-4.53%
XMR$358.43+1.99%
TJX, Lowe’s, and United Therapeutics reported quarterly results that topped expectations, highlighting steady growth across retail and biotech.
TJX posted Q3 EPS of $1.28 on $15.1 billion in revenue, beating expectations and prompting the company to raise its FY26 guidance.
The TJX Companies, Inc. (NYSE: TJX) reported net sales of $16.4 billion for the fourth quarter of Fiscal 2025.
The TJX Companies, Inc. (NYSE: TJX) reported a robust performance for the third quarter of Fiscal Year 2025.
TJX reported an EPS of $1.03 and revenue of $13.3 billion for the third quarter.